Quantcast
Channel: MassDevice
Browsing all 17804 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Texas DePuy hip implant lawsuit docket tops 750 complaints

A Texas multi-district lawsuit against Johnson & Johnson subsidiary DePuy Orthopaedics over metal-on-metal hip implants failures grows to include more than 750 complaints transferred from federal...

View Article



Image may be NSFW.
Clik here to view.

Bzzzzaaaap

By Westby G. Fisher, MD, FACCImagine: doctors everywhere using cellphones.   Better yet, imagine doctors using cellphones to help care for patients. It's a beautiful thing, really: efficient, timely,...

View Article

Image may be NSFW.
Clik here to view.

Emblation lands CE Mark for Swift microwave therapy system

Emblation receives CE Mark approval in European Union to market its Swift microwave therapy system, which treats skin lesions.Scotland, UK-based Emblation landed CE Mark approval for its Swift...

View Article

Image may be NSFW.
Clik here to view.

FDA clears Vitacon’s non-invasive bladder scanner

Vitacon receives FDA clearance for its VitaScan LT USB bladder scanner, and lands a partnership with a Minneapolis-based lifescience advisory firm for marketing and distribution in the U.S. Trondheim,...

View Article

Image may be NSFW.
Clik here to view.

St. Jude Medical wins European approval for heart valve

The European Union grants CE Mark approval for St. Jude Medical's Portico transcatheter aortic valve implant.News Well, CE Mark, Regulatory/Compliance, Replacement Heart Valvesread more

View Article


Image may be NSFW.
Clik here to view.

Imagine Eyes lands CE Mark for its retinal camera

Ophthalmology devices maker Imagine Eyes’ imaging system receives CE Mark approval in European Union for clinical use. Orsay, France-based Imagine Eyes landed CE Mark approval to market its rtx1...

View Article

Image may be NSFW.
Clik here to view.

Wright merger sends BioMimetic shares up 70%

Orthopedic devices maker Wright Medical signs a definitive agreement to acquire BioMimetic Therapeutics for cash and stock payments valued at $190 million with another $190 million in contingent...

View Article

Image may be NSFW.
Clik here to view.

Shareholders sue Abiomed over Impella claims

Shareholders of medical device company Abiomed filed a purported class action lawsuit, accusing the company of inflating its stock price with rosy predictions for its flagship Impella 2.5 heart...

View Article


Image may be NSFW.
Clik here to view.

Dune Medical lands conditional approval for MarginProbe breast cancer...

The FDA awards Dune Medical Devices' MarginProbe breast cancer detection system an "approvable letter," with full approval pending final agreement on post-approval study design.Framingham, Mass.-based...

View Article


Image may be NSFW.
Clik here to view.

KCI in stealthy buyout of MoMelan | Wall Street Beat

Skin graft company MoMelan is acquired in a stealthy buyout by Kinetic Concepts Inc., Xconomy reports.Kinetic Concepts executed an under-the-radar buyout of skin graft developer MoMelan Technologies,...

View Article

Image may be NSFW.
Clik here to view.

Medical device tax: Are "lame duck" lobbying efforts in vain?

Medical device industry players have focused their latest repeal efforts on pushing Congress during the "lame duck" session after the election, but some are skeptical that the tax will be addressed...

View Article

Image may be NSFW.
Clik here to view.

Are gamers better than docs at virtual sugery?

Researchers at University of Texas Medical Branch at Galveston pitted regular video game users against MD's in a battle of virtual surgery with some surprising results.

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +3 | The top 3 med-tech stories for November 19, 2012

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the...

View Article


Image may be NSFW.
Clik here to view.

Stryker exec charged in $1.7M insider trading scheme | MassDevice.com On Call

The Securities & Exchange Commission charges Stryker marketing executive Mark Foldy alongside a handful of others in an insider trading scheme that allegedly generated $1.7 million in illegal...

View Article

Image may be NSFW.
Clik here to view.

Medtronic's Endurant III graft looks good at 2 years

2-year results from studies of Medtronic's Endurant III stent graft show continued success with the popular abdominal aortic aneurysm repair system.Medical device giant Medtronic (NYSE:MDT) touted...

View Article


Image may be NSFW.
Clik here to view.

Protect, protect, protect. Now share

By John D. Halamka, MDLater this week, I'm joining a healthsystemCIO.com webinar about security and health information exchange.News Well, Blog, Health Information Technologyread more

View Article

Image may be NSFW.
Clik here to view.

Smith & Nephew names new CFO | Personnel Moves

Smith & Nephew welcomes Julie Brown as CFO after former CFO Adrian Hennah stepped down from his position in September. Smith & Nephew names Julie Brown its new finance chiefNews Well,...

View Article


Image may be NSFW.
Clik here to view.

FDA's new unique device ID timing cuts deadlines for some device labels by 5...

New unique device identifier deadlines required by a law signed earlier this year force the FDA to shorten some of its labeling timeframes by as much as 5 years.The FDA's UDI label example: Product...

View Article

Image may be NSFW.
Clik here to view.

FDA slaps HeartSine with Class I recall

HeartSine's recall of Samaritan defibrillators gets Class I status from the FDA over concerns that battery defects could lead to patient injury or death.The FDA gave HeartSine's Samaritan defibrillator...

View Article

Image may be NSFW.
Clik here to view.

Survey: Heart docs say Edwards on track for solid heart valve growth | Wall...

Edwards Lifesciences is on track for mid-teens sales growth for its Sapien heart valve, according to a survey of 30 cardiologists by Leerink Swann analysts.Edwards Lifesciences (NYSE:EW) is on track...

View Article
Browsing all 17804 articles
Browse latest View live




Latest Images